We are live on ! Find out more
GNPX icon

Genprex

22 hedge funds and large institutions have $16.7M invested in Genprex in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

6% more capital invested

Capital invested by funds: $15.9M → $16.7M (+$895K)

2% more call options, than puts

Call options by funds: $1.2M | Put options by funds: $1.18M

0% less ownership

Funds ownership: 0%0% (-0%)

24% less funds holding

Funds holding: 2922 (-7)

70% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 10

Holders
22
Holders Change
-7
Holders Change %
-24.14%
% of All Funds
0.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
1
Closed
10
Calls
$1.2M
Puts
$1.18M
Net Calls
+$22K
Net Calls Change
+$698K

GNPX Hedge Fund Activity: Q3 2020 in Review

22 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q3 2020, worth a combined $16.7M — up 5.6% from $15.9M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of GNPX and 3 opened new positions — a net loss of 7 holders — while 1 trimmed existing stakes and 4 added.

The largest buyer was AQR Capital Management, opening a new position worth an estimated $315K. The largest seller was Sabby Management, exiting entirely with an estimated $372K sold.

  • 22 institutional investors held Genprex (GNPX) as of Q3 2020, down from 29 in Q2 2020.
  • Funds reported $16.7M of Genprex stock for Q3 2020, up 5.6% quarter-over-quarter.
  • 3 funds opened new Genprex positions in Q3 2020 and 10 closed out, a net change of -7 holders.
  • The largest Genprex buyer in Q3 2020 was AQR Capital Management, an estimated $315K added.
  • The largest Genprex seller in Q3 2020 was Sabby Management, an estimated $372K sold.

Based on aggregated 13F filings for Q3 2020.